Glucose Health (GLUC) versus Its Peers Critical Contrast

Glucose Health (OTCMKTS:GLUC) is one of 53 public companies in the “Medicinals & botanicals” industry, but how does it compare to its peers? We will compare Glucose Health to similar businesses based on the strength of its profitability, risk, valuation, earnings, institutional ownership, dividends and analyst recommendations.

Volatility & Risk

Glucose Health has a beta of 3.51, indicating that its share price is 251% more volatile than the S&P 500. Comparatively, Glucose Health’s peers have a beta of 1.47, indicating that their average share price is 47% more volatile than the S&P 500.

Profitability

This table compares Glucose Health and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glucose Health	-75.00%	N/A	N/A
Glucose Health Competitors	-41.21%	-261.73%	-7.59%

Institutional and Insider Ownership

16.7% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 22.6% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Glucose Health and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glucose Health	0	0	0	0	N/A
Glucose Health Competitors	272	555	994	74	2.46

As a group, “Medicinals & botanicals” companies have a potential upside of 47.05%. Given Glucose Health’s peers higher probable upside, analysts clearly believe Glucose Health has less favorable growth aspects than its peers.

Earnings and Valuation

This table compares Glucose Health and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Glucose Health	$540,000.00	-$420,000.00	-6.13
Glucose Health Competitors	$300.89 million	-$49.81 million	12.99

Glucose Health’s peers have higher revenue, but lower earnings than Glucose Health. Glucose Health is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Glucose Health peers beat Glucose Health on 6 of the 10 factors compared.

Glucose Health Company Profile

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.